Skip to content

Ortho-device

Active
Private limited companyfounded 201114 yrs activeGroenmolenstraat 1113, 3570 Alken, BelgiumKBO/BCE: BE 0839.691.782

Ortho-device has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €824k and a net result of €134k. Equity is growing by ~19.5% per year across the filed fiscal years. Its solvency ranks better than 55% of 16424 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
100 / 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81=
Solvency100▲+1
Growth78=
Stability100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €80k at 30 days acceptable
Liquidity ample (current ratio 4.14 against 2.86 in 2024), and 31.5% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
68.5%
Return on assets
11.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 14 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
26 d late
2024
20 d early
2023
12 d early
2022
2 d late
2021
1 d late
2020
88 d late
2019
14 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€824k▲ 19.4%
2024 · €690k
2018: €145k 2019: €251k 2020: €352k 2021: €445k 2022: €536k 2023: €639k 2024: €690k
2018 → 2025
Total assets
€1.20M▲ 5.7%
2024 · €1.14M
2018: €407k 2019: €492k 2020: €938k 2021: €919k 2022: €1.02M 2023: €1.08M 2024: €1.14M
2018 → 2025
Net result
€134k▲ 20.6%
2024 · €111k
2018: €60k 2019: €117k 2020: €111k 2021: €115k 2022: €119k 2023: €103k 2024: €111k
2018 → 2025
Working capital
€444k▲ 47.4%
2024 · €301k
2018: €53k 2019: €142k 2020: €138k 2021: €129k 2022: €136k 2023: €262k 2024: €301k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€445k-€536k▲ 20.6%€639k▲ 19.2%€690k▲ 8.0%€824k▲ 19.4%
Operating result€155k-€170k▲ 9.4%€155k▼ 9.0%€160k▲ 3.3%€201k▲ 25.9%
Net result€115k-€119k▲ 3.6%€103k▼ 13.4%€111k▲ 7.9%€134k▲ 20.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €155k€155kNet result 2021: €115k€115kOperating result 2022: €170k€170kNet result 2022: €119k€119kOperating result 2023: €155k€155kNet result 2023: €103k€103kOperating result 2024: €160k€160kNet result 2024: €111k€111kOperating result 2025: €201k€201kNet result 2025: €134k€134k20212022202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 26% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.20M
Fixed assets €618k▼ 8.5%
Current assets €585k▲ 26.4%
Equity and liabilities €1.20M
Equity €824k▲ 19.4%
Debt €379k▼ 15.5%
The debt ratio falls from 39.4% to 31.5%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€271k
2024 · €227k
Cash flow
€204k
2024 · €178k
Solvency
68.5%
2024 · 60.6%
Current ratio
4.14
2024 · 2.86
Quick ratio
3.90
2024 · 2.69
Debt / equity
0.46
2024 · 0.65
ROE
16.3%
2024 · 16.1%
ROA
11.1%
2024 · 9.8%
Interest coverage
23.96
2024 · 38.02
Debt
€379k
2024 · €448k
Debt ≤ 1 year
€141k
2024 · €162k
Debt > 1 year
€238k
2024 · €287k
Income taxes
€57k
2024 · €45k
Staff costs
€46k
2024 · €52k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.14M€1.20M
Fixed assets21/28€676k€618k
Intangible fixed assets21€1k€683
Tangible fixed assets22/27€674k€617k
Land and buildings22€481k€461k
Plant, machinery and equipment23€32k€21k
Furniture and vehicles24€6k€5k
Leasing and similar rights25€45k€34k
Other tangible fixed assets26€110k€95k
Current assets29/58€463k€585k
Stocks and contracts in progress3€27k€34k
Stocks30/36€27k€34k
Amounts receivable within one year40/41€135k€99k
Trade receivables40€135k€99k
Other amounts receivable41€0€74
Current investments50/53€30k€20k
Cash at bank and in hand54/58€256k€426k
Deferred charges and accrued income490/1€14k€6k
Equity and liabilities
Total equity and liabilities10/49€1.14M€1.20M
Equity10/15€690k€824k
Contributions10/11€12k€12k=
Reserves13€678k€812k
Distributable reserves133€678k€812k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€448k€379k
Amounts payable after more than one year17€287k€238k
Financial debts170/4€287k€238k
Amounts payable within one year42/48€162k€141k
Current portion of amounts payable after more than one year42€48k€49k
Financial debts43€10k€13k
Credit institutions430/8-€1k
Other loans439€10k€12k
Trade debts44€9k€9k
Suppliers440/4€9k€9k
Taxes, remuneration and social security45€32k€61k
Taxes450/3€27k€49k
Remuneration and social security454/9€5k€12k
Other amounts payable47/48€62k€9k
Income statement Code20242025
Non-recurring operating income76A€14k€0
Remuneration, social security and pensions62€52k€46k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€67k€70k
Other operating charges640/8€3k€3k
Gross operating margin9900€282k€319k
Operating profit (loss)9901€160k€201k
Financial income75/76B€2k€2k
Recurring financial income75€2k€2k
Financial charges65/66B€6k€11k
Recurring financial charges65€6k€11k
Profit (loss) for the period before taxes9903€156k€192k
Income taxes67/77€45k€57k
Profit (loss) for the period9904€111k€134k
Profit (loss) for the period to be appropriated9905€111k€134k
Appropriation of the result
Profit (loss) to be appropriated9906€111k€134k
Transfer from equity791/2€60k€0
Transfer to equity691/2€111k€134k
To other reserves6921€111k€134k
Profit to be distributed694/7€60k€0
Return on contributions (dividend)694€60k€0

The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 26 days late
2025
31-12
Financial Highest result since 2018net €134k ▲20.6%
Operating result €201k, net result €134k, both a record.
11-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
19-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
02-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 2 days late
2022
31-12
Financial Equity above €500kEq €536k ▲20.6%
5 profitable years in a row build equity to €536k.
01-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 1 day late
2021
27-10
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 88 days late
2020
17-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Equity above €200kEq €251k ▲73%
2 profitable years in a row build equity to €251k.
15-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
13-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
13-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Alken · 1 establishment unit since 2011
establishment approximate The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Groenmolenstraat 11133570 Alken
Ground area
3,430 m²
Building footprint
415 m²
Volume, LiDAR
2,190 m³
Parcel 73302C0079/00D003, Flanders · tallest building 6.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Steunzool Center
Groenmolenstraat 1113, 3570 AlkenManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20112.203.229.591
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
73302C0079/00D003 Flanders 3,430 m² 1 · 415 m² 6.3 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,604 companies in sector 86220 we hold annual accounts for 7,961. 5,981 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded28-09-2011
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers

Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

3 entries
Enterprise
E-mail:tim@ortho-device.be
Enterprise
Phone:+3214756070
Enterprise